Associations of cardiovascular and diabetes-related risk factors with myocardial perfusion reserve assessed by 201Tl/99mTc-tetrofosmin single-photon emission computed tomography in patients with diabetes mellitus and stable coronary artery disease
Tóm tắt
We aimed to examine the associations of cardiovascular risk factors with myocardial perfusion reserve (MPR) in patients with type 2 diabetes and stable coronary artery disease. The study patients were retrospectively identified from a database of patients with diabetes and stable coronary artery disease at Asan Medical Center (Seoul, Republic of Korea), covering the period from 2017 to 2019. The primary outcome variable was MPR assessed by dynamic stress 201Tl/rest 99mTc-tetrofosmin SPECT. Univariable and stepwise multivariable analyses were performed to assess the associations of cardiovascular risk factors with MPR. A total of 276 patients (236 men and 40 women) were included. The median global MPR was 2.4 (interquartile range 1.9–3.0). Seventy-five (27.2%) patients had an MPR < 2.0. Multivariable linear regression showed that smoking (ß = − 0.44, 95% confidence interval − 0.68 to − 0.21, P < 0.001), hypertension (ß = − 0.24, 95% confidence interval − 0.47 to − 0.02, P = 0.033), and summed difference score (ß = − 0.05, 95% confidence interval − 0.07 to − 0.03, P < 0.001) were independently associated with MPR. Abnormal MPR (< 2.0) was associated with a higher incidence of cardiac death or myocardial infarction (P = 0.034). MPR assessed by dynamic stress 201Tl/rest 99mTc-tetrofosmin SPECT was impaired in a large cohort of patients with diabetes. After adjusting for risk variables, including standard myocardial perfusion imaging characteristics, smoking, and hypertension were associated with MPR. Our results may aid in identifying patients with impaired MPR and stratifying patients with type 2 diabetes.
Tài liệu tham khảo
Rawshani A, Rawshani A, Franzen S et al (2017) Mortality and Cardiovascular Disease in Type 1 and type 2 diabetes. N Engl J Med 376:1407–1418. https://doi.org/10.1056/NEJMoa1608664
Mosenzon O, Alguwaihes A, Leon JLA et al (2021) CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol 20:154. https://doi.org/10.1186/s12933-021-01344-0
Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, Jacobsen SJ, Frye RL, Roger VL (2002) Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 40:946–953. https://doi.org/10.1016/s0735-1097(02)02065-x
Paneni F, Beckman JA, Creager MA, Cosentino F (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 34:2436–2443. https://doi.org/10.1093/eurheartj/eht149
Taylor KS, Heneghan CJ, Farmer AJ, Fuller AM, Adler AI, Aronson JK, Stevens RJ (2013) All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 36:2366–2371. https://doi.org/10.2337/dc12-1513
Beckman JA, Paneni F, Cosentino F, Creager MA (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J 34:2444–2452. https://doi.org/10.1093/eurheartj/eht142
Murthy VL, Bateman TM, Beanlands RS et al (2018) Clinical quantification of myocardial blood Flow using PET: joint position paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol 25:269–297. https://doi.org/10.1007/s12350-017-1110-x
Shaw LJ, Iskandrian AE (2004) Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11:171–185. https://doi.org/10.1016/j.nuclcard.2003.12.004
Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, Dorbala S, Blankstein R, Di Carli MF (2012) Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 126:1858–1868. https://doi.org/10.1161/CIRCULATIONAHA.112.120402
Gulati M, Levy PD, Mukherjee D et al (2021) 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest Pain: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 144:e368–e454. https://doi.org/10.1161/CIR.0000000000001030
Di Carli MF, Janisse J, Grunberger G, Ager J (2003) Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41:1387–1393. https://doi.org/10.1016/s0735-1097(03)00166-9
Oh M, Choi JH, Kim SO, Lee PH, Ahn JM, Lee SW, Moon DH, Lee CW (2021) Comparison of empagliflozin and sitagliptin therapy on myocardial perfusion reserve in diabetic patients with coronary artery disease. Nucl Med Commun 42:972–978. https://doi.org/10.1097/MNM.0000000000001429
Han S, Kim YH, Ahn JM et al (2018) Feasibility of dynamic stress (201)Tl/rest (99m)Tc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease. Eur J Nucl Med Mol Imaging 45:2173–2180. https://doi.org/10.1007/s00259-018-4057-5
Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL (2017) Ischemia and no obstructive coronary artery Disease (INOCA): developing evidence-based therapies and Research Agenda for the Next Decade. Circulation 135:1075–1092. https://doi.org/10.1161/CIRCULATIONAHA.116.024534
Raghavan S, Vassy JL, Ho YL, Song RJ, Gagnon DR, Cho K, Wilson PWF, Phillips LS (2019) Diabetes Mellitus-Related all-cause and Cardiovascular Mortality in a national cohort of adults. J Am Heart Assoc 8:e011295. https://doi.org/10.1161/JAHA.118.011295
Di Carli MF, Charytan D, McMahon GT, Ganz P, Dorbala S, Schelbert HR (2011) Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med 52:1369–1377. https://doi.org/10.2967/jnumed.110.082883
Czernin J, Waldherr C (2003) Cigarette smoking and coronary blood flow. Prog Cardiovasc Dis 45:395–404. https://doi.org/10.1053/pcad.2003.00104
Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650–1656. https://doi.org/10.1056/NEJM199806043382302
Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell GS (1998) Cigarette smoking and progression of atherosclerosis: the atherosclerosis risk in Communities (ARIC) Study. JAMA 279:119–124. https://doi.org/10.1001/jama.279.2.119
Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A (2000) Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35:1654–1660. https://doi.org/10.1016/s0735-1097(00)00594-5
Al-Mashhadi RH, Al-Mashhadi AL, Nasr ZP et al (2021) Local pressure drives low-density lipoprotein Accumulation and Coronary Atherosclerosis in Hypertensive Minipigs. J Am Coll Cardiol 77:575–589. https://doi.org/10.1016/j.jacc.2020.11.059
Wu KY, Timmerman NP, McPhedran R, Hossain A, Beanlands RSB, Chong AY, deKemp RA (2020) Differential association of diabetes mellitus and female sex with impaired myocardial flow reserve across the spectrum of epicardial coronary disease. Eur Heart J Cardiovasc Imaging 21:576–584. https://doi.org/10.1093/ehjci/jez163
Murthy VL, Naya M, Taqueti VR et al (2014) Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 129:2518–2527. https://doi.org/10.1161/CIRCULATIONAHA.113.008507
Kim YH, Ahn JM, Park DW et al (2012) Impact of ischemia-guided revascularization with myocardial perfusion imaging for patients with multivessel coronary disease. J Am Coll Cardiol 60:181–190. https://doi.org/10.1016/j.jacc.2012.02.061
De Bruyne B, Oldroyd KG, Pijls NHJ (2016) Microvascular (dys)function and clinical outcome in stable coronary disease. J Am Coll Cardiol 67:1170–1172. https://doi.org/10.1016/j.jacc.2015.11.066
Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, Kaufmann PA (2009) Long-term prognostic value of 13 N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54:150–156. https://doi.org/10.1016/j.jacc.2009.02.069
Farhad H, Dunet V, Bachelard K, Allenbach G, Kaufmann PA, Prior JO (2013) Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging. Eur Heart J Cardiovasc Imaging 14:1203–1210. https://doi.org/10.1093/ehjci/jet068
Nkoulou R, Fuchs TA, Pazhenkottil AP et al (2016) Absolute myocardial blood Flow and Flow Reserve assessed by gated SPECT with cadmium-Zinc-Telluride detectors using 99mTc-Tetrofosmin: head-to-Head comparison with 13 N-Ammonia PET. J Nucl Med 57:1887–1892. https://doi.org/10.2967/jnumed.115.165498
Hsu B, Hu LH, Yang BH, Chen LC, Chen YK, Ting CH, Hung GU, Huang WS, Wu TC (2017) SPECT myocardial blood flow quantitation toward clinical use: a comparative study with (13)N-Ammonia PET myocardial blood flow quantitation. Eur J Nucl Med Mol Imaging 44:117–128. https://doi.org/10.1007/s00259-016-3491-5
Agostini D, Roule V, Nganoa C, Roth N, Baavour R, Parienti JJ, Beygui F, Manrique A (2018) First validation of myocardial flow reserve assessed by dynamic (99m)Tc-sestamibi CZT-SPECT camera: head to head comparison with (15)O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging 45:1079–1090. https://doi.org/10.1007/s00259-018-3958-7
Valensi P, Lorgis L, Cottin Y (2011) Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis 104:178–188. https://doi.org/10.1016/j.acvd.2010.11.013